Showing results (91-100 of 1,802) with videos related to

Sort By:
Pageof 181
Transplantation and Cellular Therapy|November 17, 2021
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation RecipientsJeremy D Rubinstein, Sonata Jodele, Daria Heyenbruch, et al.
Transplantation and Cellular Therapy|November 10, 2021
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesSara Redondo, Albert Esquirol, Silvana Novelli, et al.
Transplantation and Cellular Therapy|November 10, 2021
Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes RegistryRachel Cusatis, Kathryn E Flynn, Sumithira Vasu, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Transplantation and Cellular Therapy|March 15, 2021
Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic TransplantationN Bejanyan, I Vlasova-St Louis, H Mohei, et al.
Transplantation and Cellular Therapy|January 12, 2022
Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute LeukemiaKyung Taek Hong, Hyun Jin Park, Bo Kyung Kim, et al.
Transplantation and Cellular Therapy|January 15, 2022
Mature Naive B Cells Regulate the Outcome of Murine Acute Graft-versus-Host Disease in an IL-10-Independent MannerRômulo Gonçalves Galvani, Suelen Martins Perobelli, Triciana Gonçalves-Silva, et al.
Transplantation and Cellular Therapy|January 18, 2022
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir ProphylaxisElisa Gabanti, Oscar Borsani, Anna Amelia Colombo, et al.
Transplantation and Cellular Therapy|January 18, 2022
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center ReportAndriyana K Bankova, Joseph Caveney, Bin Yao, et al.
Transplantation and Cellular Therapy|November 14, 2021
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesTimothy D Gauntner, Claudio G Brunstein, Qing Cao, et al.
Pageof 181